Biotech Co. Accelerate Diagnostics Hits Ch. 11 With Sale Plan

Medical technology company Accelerate Diagnostics Inc. filed for Chapter 11 protection in Delaware bankruptcy court Thursday with $90.2 million of debt and a plan to sell the business to lender Indaba...

Already a subscriber? Click here to view full article